Pfizer Inc (PFE) stock

PFENYSEPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3046% above fair value

$29.45+0.09 (+0.31%)

Close on Nov 11, 2026Market cap $167.86BP/E 42.1Yield 5.84%

Pfizer operating margin

Operating margin is operating income as a percentage of revenue.

Pfizer has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is PFE.

Revenue growth1.3% · median 10.4%

Gross margin73.4% · median 71.6%

Net margin6.3% · median 14.1%

Advertisement
300 × 250

See a number that looks wrong?